Bioequivalence: The Regulatory Career of a Pharmaceutical Concept (original) (raw)
Related papers
Healthcare
Pharmacy and Public Policy: Evolution of the Legal and Regulatory Framework for Generic Interchange
The Journal of Pharmacy Technology Jpt Official Publication of the Association of Pharmacy Technicians, 2008
Journal of Applied Pharmaceutical Science, 2016
Bioequivalence of Generic Drugs Commercialised on the Canadian Market
Journal of Developing Drugs, 2015
Relevance of variation in use of terminology to define generic pharmaceutical products
Scientia Pharmaceutica, 2014
Bioequivalence Implies Therapeutic Equivalence. II. Economic and Social Approach
2017
Transnational pharmacogovernance: emergent patterns in the jazz of pharmaceutical policy convergence
Globalization and health, 2018
Generic: The Unbranding of Modern Medicine. Jeremy A.Greene, Baltimore: JHU Press, 2014, 368 pp
Medical Anthropology Quarterly, 2014
Bioequivalence for highly variable drugs: regulatory agreements, disagreements, and harmonization
Journal of Pharmacokinetics and Pharmacodynamics, 2019
Pharmaceuticals, the state and the global harmonisation process
John Christian Cedrick Erosa Abraham
Australian Health Review, 2004
Ending drug registration apartheid: taming data exclusivity and patent/registration linkage
American journal of law & medicine, 2008
Negotiating reality: the construction of enforceable pharmaceutical standards
Food and drug law journal, 2002
Research Policy, 2000
PATENTS VS. STATUTORY EXCLUSIVITIES IN BIOLOGICAL PHARMACEUTICALS— DO WE REALLY NEED BOTH
Definition and Classification of Generic Drugs Across the World
Applied Health Economics and Health Policy, 2015
Cornell international law journal, 1997
2013
Generic drugs: myths, facts, and limitations
Italian Journal of Medicine, 2012
REFERENCE BIOLOGICAL MEDICINES ('ORIGINATORS') AND 'BIOSIMILARS': COMPETITION AND PATIENT PROTECTION
Interchangeability for Biologics is a Legal Distinction in the USA, Not a Clinical One
BioDrugs
Bioequivalence requirements for generic products
Pharmacology & Therapeutics, 1994
of Generic Entry: The Role of Physicians and of Non-Bioequivalent Competitors
2007
Regulating Medicines in a Globalized World With Increased Recognition and Reliance Among Regulators
JAMA
Global intellectual property protection of “innovative” pharmaceuticals
Distributive justice and the introduction of generic medicines
Health Care Analysis, 2002
Background Document: The Global Regulation of Medicines
Background Document: The Global Regulation of Medicines, 2013
The AAPS Journal, 2013